Selective field potential changes induced by L-DOPA.
D000818:Animals; D001307:Auditory Perception / Q000187:drug effects*; D001309:Auditory Threshold / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001931:Brain Mapping; D002421:Caudate Nucleus / Q000187:drug effects; D005071:Evoked Potentials / Q000187:drug effects*; D005829:Geniculate Bodies / Q000187:drug effects; D005917:Globus Pallidus / Q000187:drug effects; D007032:Hypothalamus, Anterior / Q000187:drug effects; D007033:Hypothalamus, Middle / Q000187:drug effects; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013378:Substantia Nigra / Q000187:drug effects
D007980:Levodopa; D012110:Reserpine; D010424:Pentobarbital